(Q38168120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

main subject

heart failure

0 references

congestive heart failure

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Manuel Alfredo Podestà

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Giorgio Graziani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Daniela Pini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Silvia Oldani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Salvatore Badalamenti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

published in

Heart Failure Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

699-708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10741-013-9416-5

2 March 2020

exact match

0 references

cites work

EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Heart failure-related hospitalization in the U.S., 1979 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Cardiorenal Syndrome: The Clinical Cardiologists' Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Congestion in acute heart failure syndromes: an essential target of evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Patterns of weight change preceding hospitalization for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

The pathophysiology of acute heart failure--is it all about fluid accumulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Pathophysiologic targets in the early phase of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Hormones and hemodynamics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

ABC of heart failure. Pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Mechanisms of fibrosis: the role of the pericyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Neurohormonal activation in congestive heart failure and the role of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

The prognostic importance of different definitions of worsening renal function in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Medical management of advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Raised venous pressure: a direct cause of renal sodium retention in oedema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Diagnostic value of patterns of symptoms and signs of heart failure: application of latent class analysis with concomitant variables in a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

GFR estimation using cystatin C is not independent of body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Accuracy of cystatin C-based estimates of glomerular filtration rate in kidney transplant recipients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Loop diuretics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Diuretic strategies in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Diuretics and ultrafiltration in acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Diuretic therapy and resistance in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Rubbing salt into wounds: hypertonic saline to assist with volume removal in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Human serum albumin in the clinical syndrome of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Oral tolvaptan is safe and effective in chronic hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Effects of tolvaptan on dyspnoea relief from the EVEREST trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Tolvaptan for the treatment of heart failure: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Mechanisms of solute transport in extracorporeal therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Technical aspects of extracorporeal ultrafiltration: mechanisms, monitoring and dedicated technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Ultrafiltration in decompensated heart failure with cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9416-5

Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology

21 January 2018

1 reference

12 December 2020

Ultrafiltration in heart failure

1 reference

12 December 2020

The inhibitory effect of diuretics on carbonic anhydrases

1 reference

12 December 2020

Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration

1 reference

12 December 2020

Pathophysiology of sodium and water retention in heart failure

1 reference

12 December 2020

Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system

1 reference

12 December 2020

Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Heart failure with preserved ejection fraction: treat now by treating comorbidities

1 reference

12 December 2020

1 reference

12 December 2020

Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis

1 reference

12 December 2020

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)

1 reference

12 December 2020

10.1007/S10741-013-9416-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297366%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference